DERIVATIVES OF DOLASTATIN-15
FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to derivatives of dolastatin-15 of the general formula (I): A-B-D-E-F-(G)r-(K)s-L where A, B, D, E, F, G and K mean residues of alpha-amino acids; s and r each means independently 0 or 1; L means monovalent radical, for examp...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BARLOTSTSARI TEREZA TSIRKE TOMAS KLING ANDREAS KHAUPT ANDREAS JANSSEN BERND |
description | FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to derivatives of dolastatin-15 of the general formula (I): A-B-D-E-F-(G)r-(K)s-L where A, B, D, E, F, G and K mean residues of alpha-amino acids; s and r each means independently 0 or 1; L means monovalent radical, for example, amino-group, N-substituted amino-group, beta-hydroxylamino-group, hydrazido-group, alkoxy-group, thioalkoxy-group, aminooxy-group or oximato-group. Except for, invention involves method of cancer treatment in mammal, for example, in humans that includes administration to mammal the effective amount of compound of the formula (I). EFFECT: valuable medicinal properties of derivatives. 39 cl, 3 tbl |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2195462C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2195462C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2195462C23</originalsourceid><addsrcrecordid>eNrjZJBxcQ3yDHMM8QxzDVbwd1Nw8fdxDA4B8v10DU15GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakl8UKiRoaWpiZmRs5ExEUoALbEgcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DERIVATIVES OF DOLASTATIN-15</title><source>esp@cenet</source><creator>BARLOTSTSARI TEREZA ; TSIRKE TOMAS ; KLING ANDREAS ; KHAUPT ANDREAS ; JANSSEN BERND</creator><creatorcontrib>BARLOTSTSARI TEREZA ; TSIRKE TOMAS ; KLING ANDREAS ; KHAUPT ANDREAS ; JANSSEN BERND</creatorcontrib><description>FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to derivatives of dolastatin-15 of the general formula (I): A-B-D-E-F-(G)r-(K)s-L where A, B, D, E, F, G and K mean residues of alpha-amino acids; s and r each means independently 0 or 1; L means monovalent radical, for example, amino-group, N-substituted amino-group, beta-hydroxylamino-group, hydrazido-group, alkoxy-group, thioalkoxy-group, aminooxy-group or oximato-group. Except for, invention involves method of cancer treatment in mammal, for example, in humans that includes administration to mammal the effective amount of compound of the formula (I). EFFECT: valuable medicinal properties of derivatives. 39 cl, 3 tbl</description><edition>7</edition><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021227&DB=EPODOC&CC=RU&NR=2195462C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021227&DB=EPODOC&CC=RU&NR=2195462C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BARLOTSTSARI TEREZA</creatorcontrib><creatorcontrib>TSIRKE TOMAS</creatorcontrib><creatorcontrib>KLING ANDREAS</creatorcontrib><creatorcontrib>KHAUPT ANDREAS</creatorcontrib><creatorcontrib>JANSSEN BERND</creatorcontrib><title>DERIVATIVES OF DOLASTATIN-15</title><description>FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to derivatives of dolastatin-15 of the general formula (I): A-B-D-E-F-(G)r-(K)s-L where A, B, D, E, F, G and K mean residues of alpha-amino acids; s and r each means independently 0 or 1; L means monovalent radical, for example, amino-group, N-substituted amino-group, beta-hydroxylamino-group, hydrazido-group, alkoxy-group, thioalkoxy-group, aminooxy-group or oximato-group. Except for, invention involves method of cancer treatment in mammal, for example, in humans that includes administration to mammal the effective amount of compound of the formula (I). EFFECT: valuable medicinal properties of derivatives. 39 cl, 3 tbl</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJBxcQ3yDHMM8QxzDVbwd1Nw8fdxDA4B8v10DU15GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakl8UKiRoaWpiZmRs5ExEUoALbEgcA</recordid><startdate>20021227</startdate><enddate>20021227</enddate><creator>BARLOTSTSARI TEREZA</creator><creator>TSIRKE TOMAS</creator><creator>KLING ANDREAS</creator><creator>KHAUPT ANDREAS</creator><creator>JANSSEN BERND</creator><scope>EVB</scope></search><sort><creationdate>20021227</creationdate><title>DERIVATIVES OF DOLASTATIN-15</title><author>BARLOTSTSARI TEREZA ; TSIRKE TOMAS ; KLING ANDREAS ; KHAUPT ANDREAS ; JANSSEN BERND</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2195462C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2002</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>BARLOTSTSARI TEREZA</creatorcontrib><creatorcontrib>TSIRKE TOMAS</creatorcontrib><creatorcontrib>KLING ANDREAS</creatorcontrib><creatorcontrib>KHAUPT ANDREAS</creatorcontrib><creatorcontrib>JANSSEN BERND</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BARLOTSTSARI TEREZA</au><au>TSIRKE TOMAS</au><au>KLING ANDREAS</au><au>KHAUPT ANDREAS</au><au>JANSSEN BERND</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DERIVATIVES OF DOLASTATIN-15</title><date>2002-12-27</date><risdate>2002</risdate><abstract>FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to derivatives of dolastatin-15 of the general formula (I): A-B-D-E-F-(G)r-(K)s-L where A, B, D, E, F, G and K mean residues of alpha-amino acids; s and r each means independently 0 or 1; L means monovalent radical, for example, amino-group, N-substituted amino-group, beta-hydroxylamino-group, hydrazido-group, alkoxy-group, thioalkoxy-group, aminooxy-group or oximato-group. Except for, invention involves method of cancer treatment in mammal, for example, in humans that includes administration to mammal the effective amount of compound of the formula (I). EFFECT: valuable medicinal properties of derivatives. 39 cl, 3 tbl</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_RU2195462C2 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
title | DERIVATIVES OF DOLASTATIN-15 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T15%3A51%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BARLOTSTSARI%20TEREZA&rft.date=2002-12-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2195462C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |